Benzonatate Capsule
Product Images NDC 68071-2562

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Benzonatate (NDC 68071-2562). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 2562 3)

Pdp (68071 2562 3)
uCare Pharmaceuticals, Inc. provides a medication called Benzonatate 200mg in capsule form. The capsules are yellow and contain Beruopsiie USP. The medication should be stored at a controlled temperature between 68-77°F and kept out of reach of children. Patients are advised to contact their doctor for medical advice about side effects, and can also report side effects to the FDA. Lot and serial numbers are provided on the packaging.*
FDA Label Image

Benzonatate-struct (Benzonatate Struct)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.